前列腺动脉栓塞术治疗良性前列腺增生:系统评价与Meta分析
该系统评价与Meta分析纳入13项研究共1254例患者,评估前列腺动脉栓塞术(PAE)治疗良性前列腺增生所致下尿路症状的疗效与安全性。12个月随访时所有结局指标均获统计学显著改善,主要并发症发生率为0.3%,作者认为PAE可减轻中重度下尿路症状且并发症风险低。
要点
- PAE术后12个月IPSS改善67%,所有结局指标均统计学显著改善。
- 主要并发症发生率仅0.3%,作者认为PAE并发症风险低。
- 锥形束CT可能降低非靶栓塞风险。
核心结论
- 作者认为PAE可减轻良性前列腺增生男性的中重度下尿路症状,且并发症风险低。
研究设计与样本
- 按照PRISMA指南进行的系统评价与Meta分析,检索PubMed、Web of Science、Cochrane Library和Embase数据库,纳入13项研究共1254例患者,纳入标准为研究PAE疗效、参与者超过10例且随访超过6个月,采用随机效应模型汇总基线平均变化。
诊断标准与关键数值
- 12个月随访时IPSS、生活质量、IIEF-5、前列腺体积、PSA、Qmax、PVR及并发症所有 investigated 结局均见统计学显著改善(p值<0.05)。
- PAE使IPSS改善67%。
- 主要并发症报告率为0.3%。
- 纳入研究中可进行Meta分析的患者为中重度下尿路症状,平均IPSS为23.5。
临床应用与阅片要点
- 作者认为锥形束CT的使用可能降低非靶栓塞风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Prostate artery embolisation (PAE) is a new minimally invasive treatment for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH). The purpose of this study was to review the efficacy and safety of PAE in the treatment of BPH with LUTS.
METHODS: A systematic review performed according to the PRISMA guidelines with a pre-specified search strategy for PubMed, Web of Science, Cochrane Library and Embase databases protocol (PROSPERO ID: CRD42017059196). Trials studying the efficacy of prostate artery embolisation to treat LUTS with more than ten participants and follow-up longer than 6 months were included by two independent authors. Outcomes investigated were International Prostate Symptom Score (IPSS), quality of life (QoL), International Index of Erectile Function (IIEF-5), prostate volume (PV), prostate-specific antigen (PSA), peak void flow (Qmax), post-void residual (PVR) and complications. To summarise mean change from baseline, a meta-analysis was done using the random-effects model.
RESULTS: The search returned 210 references, of which 13 studies met the inclusion criteria, representing 1,254 patients. Patients in the included studies with data available for meta-analysis had moderate to severe LUTS and a mean IPSS of 23.5. Statistically significant (p value < 0.05) improvements of all investigated outcomes were seen at 12-month follow-up. Major complications were reported in 0.3% of the cases.
CONCLUSIONS: Our findings suggest that PAE can reduce moderate to severe LUTS in men with BPH with a low risk of complications.
KEY POINTS: • Prostate artery embolisation (PAE) improved International Prostate Symptom Score (IPSS) by 67%. • Major complications after PAE are very rare. • Use of cone-beam CT may reduce risk of non-target embolisation.
引用
- Malling B, Røder MA, Brasso K, et al. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol. 2018. PMID: 29948079. doi:10.1007/s00330-018-5564-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。